|
1 Hoelzer D, Gokbuget N, Ottmann O, et al. Acute lymphoblastic leukemia. Hematology,2002, 162-192.
|
|
2 Cazzaniga G, Biondi A. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Haematologica,2005, 90: 382-390.
|
|
3 DiGiuseppe JA. Acute lymphoblastic leukemia: Diagnosis and detection of minimal residual disease following therapy. Clin Lab Med,2007, 27:533-549.
|
|
4 Weir EG, Cowan K, LeBeau P, et al. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry. Implications for residual disease detection. Leukemia,1999,13:558-567.
|
|
5 Weir EG,Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol, 2001, 38:124-138.
|
|
6 Huh YO, Ibrahim S. Immunophenotypes in adult acute lymphocytic leukemia:Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am, 2000,14:1251-1265.
|
|
7 Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residue disease in childhood actue lymphoblastic leukemia. Blood,2000,96: 2691-2696.
|
|
8 Dworzak MN, Froschl G, Printz D, et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood,2002,99:1952-1958.
|
|
9 Coustan-Smith E, Sancho J, Behm FG, et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood, 2002,100:52-58.
|
|
10 Campana D. Determination of minimal residual disease in leukaemia patients. Br J Haematol, 2003,121:823-838.
|
|
11 Campana D, Coustan-Smith E. Minimal residual disease studies by flow cytometry in acuteleukemia. Acta Haematol, 2004,112:8-15.
|
|
12 Coustan-Smith E,Gajjar A, Hijiya N,et al. Clinical significance of minimal residue disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia, 2004,18: 499-504.
|
|
13 Xu C, Zhao HJ, Wu ZH, et al. Detection of minimal residual disease in childhood B ALL by flow cytometry. Chin J Hematol,2003,24(6):295-299.[徐翀，赵惠君，吴政宏等．流式细胞术检测儿童B细胞急性淋巴细胞白血病微小残留病．中华血液学杂志，2003,24(6):295-299.]
|
|
14 Wu M, Sun XF, Xu ZM, et al. Flow cytometric detection of minimal residual disease in precursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations. J Exp Hematol,2005,13(4)：557-562.[吴铭，孙雄飞，徐肇明等．基于细胞表型异常的流式细胞术检测急性前体B细胞白血病微小残留病．中国实验血液学杂志，2005,13(4):557-562.]
|
|
15 Liu YR, Wang H, Chang Y, et al. Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry. Chin J Hematol,2005,26(6):327-331.[刘艳荣，王卉，常艳等．四色流式细胞术检测B细胞急性淋巴白血病微小残留病．中华血液学杂志，2005,26(6):327-331.]
|
|
16 Zhang LP, Cheng YF, Liu GL, et al. The clinical significance of detecting minimal residual disease in childhood B-lineage actue lymphoblastic leukemia with flow cytometry. Chin J Pediatr,2005,43(7)：481-485.[张乐萍，程翼飞，刘桂兰等．急性B淋巴细胞白血病患儿微小残留病流式细胞术检测的临床意义．中华儿科杂志，2005,43(7)：481-485.]
|
|
17 Tie LJ, Gu LJ, Chen J,et al. Prognostic value of minimal residual disease in childhood B-lineage acute lymphoblastic leukemia. Chin J Hematol,2006,27(2)：120-123.[帖利军，顾龙君，陈静等．儿童急性淋巴细胞白血病治疗中微量残留病动态监测及其意义．中华血液学杂志，2006,27(2)：120-123.]
|
|
18 Liu YR, Zhang LP, Chang Y, et al. Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage actue lymphoblastic leukemia. Chin J Hematol,2006,27(5)：302-305.[刘艳荣，张乐萍，常艳等．四色流式细胞术检测B细胞急性淋巴白血病微小残留病的临床意义．中华血液学杂志，2006,27(5)：302-305.]
|
|
19 Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, 1998, 351: 550-554.
|
|
20 Dworzak MN,Froschl G,Printz D, et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood,2002,99:1952-1958.
|
|
21 Szczepanski T. Why and how to quantify minimal residue disease in acute lymphoblastic leukemia? Leukemia,2007, 21: 622-626.
|
|
22 Orfao A, Lo'pez A, Flores J,et al. Diagnosis of hematological malignancies: New applications for flow cytometry. Hematology(EHA Educ Program),2006,2:6-13.
|
|
23 Borowitz MJ, Bray R, Gascoyne R, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation. Cytometry, 1997,30:236-244.
|
|
24 Gaipa G, Basso G, Maglia O, et al. Drug-induced immunophenotypic modulation in childhood ALL: Implications for minimal residual disease detection. Leukemia, 2005, 19:49-56.
|
|
25 Van der Sluijs-Gelling AJ, van der Velden VH, Roeffen ET, et al. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death. Leukemia,2005,19:1845-1847.
|
|
26 Van Wering ER, Beishuizen A, Roeffen ET, et al. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia,1995,9:1523-1533.
|
|
27 Campana D, Biondi A, van Dongen JJ. Minimal residual disease. In: Pui CH, editor. Childhood leukemias. 2nd edition. Cambridge(UK): Cambridge University Press, 2006,679-706.
|
|
28 DiGiuseppe JA, Borowitz MJ. Leukemias and lymphomas. In: Diamandis EP, Fritsche HA, Lilja H, et al, editors. Tumor markers. Washington DC: AACC Press, 2002,321-328.
|
|
29 Wang H, Liu YR, Chen SS, et al. Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry.J Exp Hematol,2003 ,11(2)：137-141.[王卉，刘艳荣，陈珊珊等．四色流式细胞术分析B细胞型急性淋巴白血病免疫表型．中国实验血液学杂志，2003,11(4):137-141.]
|
|
30 Griesinger F,Piro-Noack M, Kaib N, et al. Leukemia-associated immunophenotypes(LAIP)are observed in 90% of adult and childhood acute lymphoblastic leukemia: Detection in remission marrow predicts outcome. Br J Hematol, 1999,105:241-255.
|
|
31 Zhu P, Liu JH. The diagnosis and detection of MRD. Mod Med, 1998,4(4):26-31.[朱平，刘继华．残留白血病的检测与诊断．当代医药，1998,4(4):26-31.]
|